Mitragynine and 7-hydroxymitragynine are among kratom’s best-studied bioactive compounds.
Much remains unknown about the substance’s long-term safety and therapeutic potential, and no kratom use is FDA-approved as safe and effective medical treatment. Because products vary, a label may not accurately predict potency, contents, or effects. This uncertainty matters when evaluating both an isolated adverse reaction and a continuing pattern of use.
